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57+ 1.3% SE). Mean 3 DPV waa 9.1 + 2.4 ml (SE), 3 DPA was 4.6+ 1.1
(SE) cm2. 3D laaflet thickness (mean 0.33 + 0.2 cm) correlated well with
actual tissue thickness (mean 0.37 + 0.03 cm): r = 0.75, p -=0.003. Corre-
lations of 3DPV and 3DPA with excised tiasue weight (g) were r = 0.75, p <
0.02 and r= 0.64, p <0.04, respectively. Forccmelations with biomechanioal
alterationa see table:
Stiffness(kPa) Failure tension(Nlmm) FailureLoad (g)
3DPV y = –37.8x + 1811 y = 21.9x+ 521 y = 28,8X+ 400
(mm) r = –0.64, p <0,04 r = 0.82, p <0.02 r= 0.76, p c 0,04
Conclusions.’1.3-D echo quantification of mitral valve prolapse isastrong
predictor of the atrength and extensibility of the myxomatous mitral valve and
may provide important new information on patient selection for mitral valve
repair.
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Three-dimensional (3-D) echoosrdiography with 3-D reconstruction system
(Echoecan, Tomtec) provides realistic visualization of cardiac morphology.
Furthermore, axtraoted 3-D imaga can be obtained by this 3-D system. Ex-
tracted 3-D images of the mitral annulus from 3-D date sets may be useful
in the evaluation of the configuration of the mitral annulus in patients with
annuloplasty ring. Thus, we reconstructed extracted 3-D images from 3-D
data sets obatained by multilane transesophageal echocerdiography, and
evaluated the configuration of the mitral annulus in patients with annulopleety
ring. Twenty patients who underwent mitral valve repair for pure mitral regur-
gitation (10 with a flexible Duran ring; D-ring, and 10 with a rigid Carpenter
ring; C-ring) were examined with 3-D echocerdiography. The extracted 3-D
images of the mitral annulus were reconstructed from the original 3-D data
sets. The mitral annular planarity waa assessed from measurement of the
angle “A” of the mitral annulus from the extracted 3-D images of the mitral
annulus es demonstrated in the figures.
Results were shown in the following table. In patients with a D-ring, the
configuration of tha mitral annulua is nonplanar, and the nonplanar configu-
ration of the annulua is more evident at end-systole. The mitral annulus in
patients with a C-ring has a planar configuration.
The angle “A”(degree) P
End-diaatole End.syatole
D-ring 119 * 17* 91 * 15* <0.05
C-ring 1s0 i 12 17s i 14 NS
*p< 0.05 vs C-ring
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Conclusion: Extracted 3-D images of the mitral annulus is useful in the
evaluation of the annular configuration in patients with an annuloplasty ring.
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Objectives: The accuracy of mitral valve orifice area (MVA) measurement
from three-dimensional echocardiographic (3DE) image data-sets obtained
by a transthoracic or transeaophageal rotational imaging probe was studied
in 15 patients with native mitral stenosis. The smallest MVA waa identified
from a set of 8 parallel short-axis cutplanes of the mitral valve between the
annulus and the tips of leaflets (paraplane echocardiography) and meaaured
by planimetty. In addition MVA was measured from the two-dimensional
short axis view (2DE). Values of MVA maasured by 3DE and 2DE were
compared with those calculated from Doppler pressure half-time (PHT) as a
gold standard. Obsetver variabilities were studied for 3DE.
Results: MVA measured from PHT ranged between 0.55 to 3.19 cm2
(mean + SD: 1.57 + 0.73), from 3D-Echo ranged between 0.83 and 3.23
Cmz (mean ~ SD: I .55 +0.67) and from 2D-Echo ranged between 1.27 and
4.08 cmz (mean + SD: 1.9 & 0.7). The variability of intra- and interobserver
measurements for 3DE measurements were not significantly different (p =
0,79 and p = 0.66, respectively), and interobserver variability was (SEE
= 0.25). There was excellent correlation, close limits of agreement (mean
difference + 2SD) and nonsignificant differences between 3DE and PHTfor
MVA measurements {r= 0.98, (0.02 + 0.3) and p = 0.6}, respectively. While
there was moderate correlation, wider limits of agreement and significant
difference between 2DE and PHT for MVA measurements {r= 0.89, (–0.32
+ 0.66) and p = 0.002), respectively.This may be related to the difficulties in
visualization the smallest orifice in precordial shorkexis views.
Conclusions: The present study suggests that three-dimensional image
data-sets byproviding thepossibilityof “computerslicing’’togenerate equidis-
tant parallel cross-sections of the mitral valve independent from physically
dictated ultrasonic windows allow accurate and reproducible measurement
of the mitral valve orifice area.
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Plasminogen activator inhibitor (PAI-1) and lipoprotein(a) [(Lp(a)], plasma
levels of which rise in women following menopause, maybe of pathogenetic
importance in atherogenesis and acute coronary syndromes by inhibiting
fibrinolysis on vaacular surfaces. Endothelial cells in culture synthesize and
releasa PAI-I to stimuli such as Lp(a). Howevar, PAI-I is synthesized in other
tissues of the body, especially in the liver. We used two different routes of
estrogen administration in order to assessthe mechanism of hormonal effects
on PAI-I antigen levels in postmenopausal women (PMW). We administered
conjugated equine estrogen (CE) 0.625 mg daily or 17p-estradiol (Ez.)0.1
mg transdermal patch to 30 and to 20 PMW, respectively. Oral CE lowered
low-density lipoprotein cholesterol (LDL-C) levels by 14 + 9% (mean + SD)
and increased high-density lipoprotein cholesterol (HDL-C) levels by 19 +
13% (both p < 0.001). CE reduced PAI-I from 31 + 34 to 14 + 10 ng/mL
(P= 0.001), and Lp(a) from 29.9+ 22.5 to 26.7 + 20.2 mg/dL (p = 0.07). in
contrast, transdermal Ez neither lowered LDL-C levels nor increased HDL-C
levels. Further, transdarmal Ez reduced neither PAI-1 (20.3 + 12.1 to 22.2
* 12.3 ng/mL) (p = 0.606) nor Lp(a) Iavels (25.5 + 20.3 to 26.6 + 24.9
mg/dL) (p = 0.525). Thus, only orally administered estrogen improvas the
fibrinolytic profile of PMW by reducing PAI-I and Lp(a) levels, likely due
to effects on hepatic synthasis of these substances, and thus may provide
greater cardiovascular protection than transdermal application of estrogen.
